In Brief: Idun Pharmaceuticals
Executive Summary
Idun Pharmaceuticals: Michael Aylott to president and CEO of the early-stage San Diego anti-apoptosis therapy biotech. Aylott was formerly with Marion Merrell Dow as president and CEO of the company's Japanese subsidiary and Pacific division...